Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...

Decongestants (oral or nasal) Nasal steroid sprays, such as Nasonex (mometasone furoate monohydrate ... If this isn't effective, you can also try using a humidifier, saline nasal spray, or ...

Total symptom scores, nasal obstruction, and doctor and patient perception of improvement were measured as markers of disease severity. Results: Although not statistically significant, both ...

Nasal decongestant spray can help relieve sinus infection symptoms in the short term. But you should limit your use to no more than 3 days to avoid a rebound effect, which can lead to worsening ...

The Annals of Pharmacotherapy. 2009;43(3):519-527.